Mouse Anti-Human Cystatin A Monoclonal Antibody, Unconjugated, Clone 224705 from R&D Systems
Acc I from Takara Mirus Bio
Microlite 2+ Plate from Thermo Scientific
... low temperature freezers offer a superior sample ...samples with high capacities. Innovative insulatio... excellent warming protection and ensure low energ...fy tracking of sample location and maximize sample...
Biology Products:(Date:11/23/2009)...sociated strain of the deadly superbug MRSAan infe...tibioticsposes a far greater health threat than pr...s, according to a study in the December issue of ... is easily picked up in fitness centers, schools, ...all burden of MRSA within hospitals, the report fo...
(Date:11/23/2009)...ervation Society says that western lowland gorilla...part of the "mother lode" of more than 125,000 gor...y threatened by growing humans activity in the reg...amp forests adjacent to the southwest border of La...med that high densities of the great apes still ex...
(Date:11/23/2009)...vides "incontrovertible evidence" that the volcani...about 73,000 years ago deforested much of central ...chers report. , The volcano ejected an estimated...leaving a crater (now the world,s largest volcanic...rs wide. Ash from the event has been found in Indi...
Breaking Biology News(10 mins):New study finds MRSA on the rise in hospital outpatients 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Cardiac Patients Across Rural America Risk Losing Access to Nearby Care as Federal Agency Considers Cuts this Week 60042 1Cardiac Patients Across Rural America Risk Losing Access to Nearby Care as Federal Agency Considers Cuts this Week 60042 2Cardiac Patients Across Rural America Risk Losing Access to Nearby Care as Federal Agency Considers Cuts this Week 60042 3Wellcome Trust funds dengue fever research in Leuven 10516 1Wellcome Trust funds dengue fever research in Leuven 10516 2Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Gly 60041 1Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Gly 60041 2Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Gly 60041 3Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Gly 60041 4Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Gly 60041 5Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Gly 60041 6Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Gly 60041 7Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Gly 60041 8(Date:11/24/2009)... The New York investment bank KTA Capital,s c...eed an AU$6.7 mil convertible note private placeme... placement was arranged by KTA Capital as Neuren,s... New York (PRWEB) November 23, 200...Capital, LLC ("KTA Capital") has announc...
(Date:11/24/2009)....24/PRNewswire-FirstCall/--Sigma-AldrichCorporatio...erenceonTuesday,December1stat1:45PMGMTinLondon,7:4...oadcastovertheInternetavailableat http://inve s ...Webcast"icontoaccessthisfile. ,, AboutSigma-A...Technologycompany.Itschemicalandbiochemicalproduct...
(Date:11/24/2009)...if.,Nov.24/PRNewswire-FirstCall/--NeurogesX,Inc.(N...velopingandcommercializingnovelpainmanagementthera...ChiefExecutiveOfficer,isscheduledtopresentatthe21s...cember1-2,2009atTheNewYorkPalaceHotelinNewYork,New...ancialOfficer,willbeavailabletorespondtoquestionsd...
(Date:11/24/2009)...acyendpointhasbeenmetforpatientswithadvanced-stage...ov.24/PRNewswire-FirstCall/-AEternaZentarisInc.(NA...aceuticalcompanyfocusedonendocrinetherapyandoncolo...udywithitstargetedcytotoxicpeptideconjugate,AEZS-1...ntendometrialcancer.Inapersonalizedhealthcareappro...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4